PRESENCE OF HETEROGENEOUS THYROID-STIMULATING ANTIBODIES IN SERA FROMINDIVIDUAL GRAVES PATIENTS AS SHOWN BY SYNTHESIZED THYROTROPIN RECEPTOR PEPTIDE APPLICATION - EVIDENCE SHOWING 2 INDEPENDENT EPITOPES AND APOSSIBLE RECOGNITION OF 2 EPITOPIC REGIONS BY ONE ANTIBODY MOLECULE
H. Sugawa et al., PRESENCE OF HETEROGENEOUS THYROID-STIMULATING ANTIBODIES IN SERA FROMINDIVIDUAL GRAVES PATIENTS AS SHOWN BY SYNTHESIZED THYROTROPIN RECEPTOR PEPTIDE APPLICATION - EVIDENCE SHOWING 2 INDEPENDENT EPITOPES AND APOSSIBLE RECOGNITION OF 2 EPITOPIC REGIONS BY ONE ANTIBODY MOLECULE, European journal of endocrinology, 133(3), 1995, pp. 283-293
To define the epitope(s) of stimulating thyrotropin receptor antibody
(TSH-R-Sab), we synthesized 19 oligopeptides covering almost all amino
acids of the extracellular domain of the human TSH-R and studied thes
e effects on the inhibition of one TSH-R-Sab activity. Four of the 19
peptides encompassing residues 31-50 (P31-20), 91-119 (P91-29), 287-30
4 (P287-18) and 354-367 (P354-14) were found to show significant TSH-R
-Sab inhibition and to have similar effects on the other three Graves'
immunoglobulins. When these peptides were applied in combination with
P354-14 only P287-18 revealed additional effects but the other two co
mbinations did not. Furthermore, sequential addition of these peptide
pairs confirmed the additional effects of P287-18 and P354-14. Sequent
ial peptide-affinity gel studies were then performed. Most of the TSH-
R-Sab activity in the unabsorbed fraction from P287-18 gel was absorbe
d to a subsequent P354-14 gel and the eluted fraction from P287-18 mos
tly remained unabsorbed by the P354-14 gel. On the other hand, most of
the unabsorbed fraction from P91-29 gel remained unabsorbed even by t
he subsequent P354-14 gel. When a P3 54-14 affinity gel-purified TSH-R
-Sab immunoglobulin was labeled and evaluated for its binding to FRTL-
5 cells, additions of original immunoglobulin, P354-14 and P91-29 resu
lted in significant inhibition of the binding but P287-18 did not affe
ct either. From these results, it was concluded that most of the indiv
idual Graves' immunoglobulins contain at least two heterogeneous moiet
ies with TSH-R-Sab activity, one of which binds P354-14 and the other
binds P287-18. Further, P354-14 and P91-29 were indicated to bind the
same molecule of TSH-R-Sab immunoglobulin.